IL22 and pulmonary fibrosis: Also, in pulmonary fibrosis, IL-22 (an anti-inflammatory cytokine of the IL-10 family) exerts an anti-fibrotic effect via inhibiting EMT by targeting alveolar epithelia, which is the only target cell type of IL-22 in the lung92,93.